Advanced in Hypertension

Hong Q. Gu

Taizhou, CN 
Advanced in Hypertension
Taizhou, CN 
OverviewLocationsClinical Research

Overview

Hong Gu practices in Taizhou, China. Ms. Gu is rated as an Advanced expert by MediFind in the treatment of Hypertension. Her top areas of expertise are Pulmonary Hypertension, Eisenmenger Syndrome, Hypertension, Hepato-Pancreato-Biliary Surgery, and Cataract Removal.

Her clinical research consists of co-authoring 83 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 31 articles and participated in 2 clinical trials in the study of Hypertension.

Gender
Female

Locations

Taizhou, 214500, China
Other Locations
Ningbo, 315000, China
Beijing, China
Longxian Chengguanzhen, China
Hong Kong, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-Label Extension Trial to Evaluate the Safety of Continued Therapy With Subcutaneous Remodulin® in Subjects With Pulmonary Arterial Hypertension Who Completed Study CVT-CV-003
An Open-Label Extension Trial to Evaluate the Safety of Continued Therapy With Subcutaneous Remodulin® in Subjects With Pulmonary Arterial Hypertension Who Completed Study CVT-CV-003
Enrollment Status: Withdrawn
Publish Date: May 09, 2017
Intervention Type: Drug
Study Phase: Phase 4
A 16-Week, Open-Label, Multi-Center, Parallel, Randomized Controlled Study to Compare the Safety, Tolerability, Pharmacokinetics and Efficacy of Slow and Rapid Dose Titration Regimens of Subcutaneous Remodulin Therapy in Subjects With Pulmonary Arterial Hypertension
A 16-Week, Open-Label, Multi-Center, Parallel, Randomized Controlled Study to Compare the Safety, Tolerability, Pharmacokinetics and Efficacy of Slow and Rapid Dose Titration Regimens of Subcutaneous Remodulin Therapy in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Withdrawn
Publish Date: May 09, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

83 Total Publications

Design, synthesis, and biological evaluation of JNK1 peptide inhibitors for alleviating insulin resistance in type 2 diabetes.
Design, synthesis, and biological evaluation of JNK1 peptide inhibitors for alleviating insulin resistance in type 2 diabetes.
Journal: European journal of medicinal chemistry
Published: May 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gu's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile